See information for patients about SUBLOCADE, including information on savings, resources, and how to get started. See Safety Info, PI, Boxed Warning & Med Guide.

Mar 23, 2026 · Sublocade (buprenorphine) is an extended-release, once-monthly subcutaneous (under the skin) injection that steadily releases buprenorphine into your bloodstream for the treatment of …

SUBLOCADE ® offers reliable buprenorphine delivery with once‑monthly dosing 1 Straightforward dosing for continuous buprenorphine delivery all month long 1 May align with patient preferences …

INDICATION SUBLOCADE is for moderate to severe opioid use disorder in those who have initiated treatment with a dose of transmucosal buprenorphine or are being treated with buprenorphine and …

Prescription SUBLOCADE, with counseling and psychosocial support, is for adults with moderate to severe opioid addiction who have started treatment with a dose of oral buprenorphine or are being …

Apr 13, 2026 · Buprenorphine for OUD is used as part of a complete treatment program that also includes counseling and behavioral therapy. For opioid use disorder, buprenorphine is available as …

Dec 16, 2024 · Find patient medical information for Sublocade (buprenorphine) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

SUBLOCADE contains buprenorphine, a partial opioid agonist, and is indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of …

Buprenorphine (Sublocade® and Brixadi®) is a medication that works in the brain to treat opioid use disorder. Opioids include heroin and prescription pain relievers such as hydrocodone, oxycodone, …

SUBLOCADE is indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are …